Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Gaudin, R. Hruban, W. Beschorner, E. Kasper, J. Olson, K. Baughman, G. Hutchins (1993)Myocarditis associated with doxorubicin cardiotoxicity.
American journal of clinical pathology, 100 2
S. Lovisa, Eliot Fletcher-Sananikone, H. Sugimoto, Janine Hensel, Sharmistha Lahiri, A. Hertig, G. Taduri, Erica Lawson, R. Dewar, I. Revuelta, Noritoshi Kato, Chang-Jiun Wu, R. Bassett, N. Putluri, M. Zeisberg, E. Zeisberg, Valerie LeBleu, R. Kalluri (2020)Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis
Science Signaling, 13
Daisy Shu, Magdalena Wojciechowski, F. Lovicu (2019)ERK1/2‐mediated EGFR‐signaling is required for TGF&bgr;‐induced lens epithelial‐mesenchymal transition
Experimental Eye Research, 178
Wencong Tian, Lei Yang, Yuansheng Liu, Jian-lin He, Liang Yang, Qiong Zhang, Fei Liu, Jing Li, Jie Liu, S. Sumi, Yanna Shen, Zhi Qi (2020)Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
The Journal of nutritional biochemistry
Hongrong Li, Qifei Zhao, Liping Chang, Cong Wei, Hongying Bei, Yujie Yin, Meng Chen, Hongtao Wang, Junqing Liang, Yiling Wu (2019)LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway
Lipids in Health and Disease, 18
W. Aird (2007)Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Circulation Research, 100
C. Liang, Lu Gao, Yuan Liu, Yuzhou Liu, R. Yao, Yapeng Li, Lili Xiao, Leiming Wu, Binbin Du, Zhen Huang, Yanzhou Zhang (2019)MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
Life sciences, 224
A. Xiong, Yi Liu (2017)Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis
Frontiers in Pharmacology, 8
Zhaohui Zhang, C. Zhai, Xue Yang, Haizhou Li, Li-Ling Wu, Li Li (2022)Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway
PLoS ONE, 17
David Monahan, Eimhear Flaherty, A. Hameed, G. Duffy (2021)Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 140
K. Sawicki, V. Sala, Lorenzo Prever, E. Hirsch, H. Ardehali, A. Ghigo (2020)Preventing and Treating Anthracycline Cardiotoxicity: New Insights.
Annual review of pharmacology and toxicology
Y. Shi, M. Moon, S. Dawood, B. McManus, Peter Liu (2011)Mechanisms and management of doxorubicin cardiotoxicity
E. Dejana, K. Hirschi, M. Simons (2017)The molecular basis of endothelial cell plasticity
Nature Communications, 8
Bronson Haynes, Li Yang, Ryan Huyck, E. Lehrer, Joshua Turner, N. Barabutis, Vanessa Correll, Allison Mathiesen, W. McPheat, O. Semmes, A. Dobrian (2019)Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.
Arteriosclerosis, Thrombosis, & Vascular Biology
O. Dagher, Pauline Mury, N. Thorin-Trescases, P. Noly, É. Thorin, M. Carrier (2021)Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases
Frontiers in Cardiovascular Medicine, 8
B. Widyantoro, N. Emoto, K. Nakayama, D. Anggrahini, S. Adiarto, Naoko Iwasa, K. Yagi, K. Miyagawa, Y. Rikitake, Takashi Suzuki, Y. Kisanuki, M. Yanagisawa, K. Hirata (2010)Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition
Z. Clayton, Vienna Brunt, D. Hutton, Nicholas VanDongen, A. D’Alessandro, J. Reisz, B. Ziemba, D. Seals (2020)Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment
JACC: CardioOncology, 2
Dong Liu, Zhiqiang Ma, Shou-yin Di, Yang Yang, Jingang Yang, Liqun Xu, R. Reiter, S. Qiao, Jiansong Yuan (2018)AMPK/PGC1&agr; activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis
Free Radical Biology and Medicine, 129
M. Milan, Valentina Pace, Fabio Maiullari, Maila Chirivì, D. Baci, S. Maiullari, L. Madaro, S. Maccari, T. Stati, G. Marano, G. Frati, P. Puri, E. Falco, C. Bearzi, R. Rizzi (2018)Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation
Cell Death & Disease, 9
R. Benjamin, G. Minotti (2021)Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection
Clinical Cancer Research, 27
Xiaobo Huang, Lingai Pan, H. Pu, Yiping Wang, Xiaoqin Zhang, Chunling Li, Zhenglin Yang (2013)Loss of caveolin-1 promotes endothelial-mesenchymal transition during sepsis: a membrane proteomic study.
International journal of molecular medicine, 32 3
Alex Chang, Victoria Garside, Michèle Fournier, Justin Smrz, P. Vrljicak, P. Umlandt, Megan Fuller, Gordon Robertson, Yongjun Zhao, Angela Tam, S. Jones, M. Marra, P. Hoodless, A. Karsan (2014)A Notch‐dependent transcriptional hierarchy promotes mesenchymal transdifferentiation in the cardiac cushion
Developmental Dynamics, 243
Yigong Shi, J. Massagué (2003)Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
E. Grakova, S. Shilov, K. Kopeva, E. Berezikova, A. Popova, M. Neupokoeva, E. Ratushnyak, A. Teplyakov (2021)Anthracycline-Induced Cardiotoxicity: The Role of Endothelial Dysfunction
Beshay Zordoky, I. Robertson, J. Dyck (2015)Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
Biochimica et biophysica acta, 1852 6
R. Zilinyi, Attila Czompa, A. Czeglédi, Andrea Gajtkó, Dora Pituk, István Lekli, Á. Tósaki (2018)The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 23
S. Piera-velázquez, S. Jimenez (2019)Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.
Physiological reviews, 99 2
P. Cipriani, P. Benedetto, P. Ruscitti, D. Capece, F. Zazzeroni, V. Liakouli, I. Pantano, O. Berardicurti, F. Carubbi, G. Pecetti, S. Turricchia, E. Alesse, M. Iglarz, R. Giacomelli (2015)The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist
The Journal of Rheumatology, 42
Yigong Shi, J. Massagué (2003)Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
Cell, 113 6
Ning Cui, Fujian Wu, Wen-jing Lu, Rui Bai, Bing-bing Ke, Taoyan Liu, Lei Li, F. Lan, M. Cui (2019)Doxorubicin‐induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes
Journal of Cellular and Molecular Medicine, 23
Yan Zhang, Yuan Dong, Zhenyu Xiong, Zhengru Zhu, Fanya Gao, Tingting Wang, Wanrong Man, Dong Sun, Jie Lin, Tongbin Li, Congye Li, Zhijing Zhao, M. Shen, Dongdong Sun, Yanhong Fan (2020)Sirt6-Mediated Endothelial-to-Mesenchymal Transition Contributes Toward Diabetic Cardiomyopathy via the Notch1 Signaling Pathway
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13
Kun Zhou, Kaiqin Tian, Bin-Jie Yan, Dan-Dan Gui, W. Luo, Zhong Ren, D. Wei, Lu-shan Liu, Zhi-Sheng Jiang (2021)A promising field: regulating imbalance of EndMT in cardiovascular diseases
Cell Cycle, 20
A. Roberts, M. Sporn, R. Assoian, J. Smith, N. Roche, L. Wakefield, U. Heine, L. Liotta, V. Falanga, J. Kehrl (1986)Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Proceedings of the National Academy of Sciences of the United States of America, 83 12
Su‐Li Cheng, J. Shao, Abraham Behrmann, Karen Krchma, D. Towler (2013)Dkk1 and Msx2–Wnt7b Signaling Reciprocally Regulate the Endothelial–Mesenchymal Transition in Aortic Endothelial Cells
Arteriosclerosis, Thrombosis, and Vascular Biology, 33
M. Kaya, M. Ozkan, O. Gunebakmaz, H. Akkaya, E. Kaya, M. Akpek, N. Kalay, M. Dikilitas, M. Yarlıoglues, H. Karaca, V. Berk, İdris Ardiç, A. Ergin, Y. Lam (2013)Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study.
International journal of cardiology, 167 5
K. Chandran, D. Aggarwal, R. Migrino, J. Joseph, D. McAllister, E. Konorev, W. Antholine, J. Zielonka, S. Srinivasan, N. Avadhani, B. Kalyanaraman (2009)Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q.
Biophysical journal, 96 4
Peter Georgakopoulos, P. Roussou, E. Matsakas, A. Karavidas, N. Anagnostopoulos, T. Marinakis, A. Galanopoulos, F. Georgiakodis, S. Zimeras, M. Kyriakidis, A. Ahimastos (2010)Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up
American Journal of Hematology, 85
S. Lipshultz, N. Rifai, V. Dalton, D. Levy, L. Silverman, S. Lipsitz, S. Colan, B. Asselin, R. Barr, L. Clavell, C. Hurwitz, A. Moghrabi, Y. Samson, M. Schorin, R. Gelber, S. Sallan (2004)The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
The New England journal of medicine, 351 2
B. Razani, X. Zhang, M. Bitzer, G. Gersdorff, E. Böttinger, M. Lisanti (2001)Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor.
The Journal of biological chemistry, 276 9
K. Leger, T. Slone, M. Lemler, D. Leonard, C. Cochran, W. Bowman, Lisa Bashore, N. Winick (2015)Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy
Pediatric Blood & Cancer, 62
M. Asensio-Lopez, A. Lax, D. Pascual-Figal, M. Valdés, J. Sánchez-Más (2011)Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system.
Free radical biology & medicine, 51 10
B. Hasinoff, Daywin Patel, Xing Wu (2019)The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent Dexrazoxane
Cardiovascular Toxicology, 20
A. Daiber, S. Steven, A. Weber, V. Shuvaev, V. Muzykantov, I. Laher, Huige Li, S. Lamas, T. Münzel (2017)Targeting vascular (endothelial) dysfunction
British Journal of Pharmacology, 174
D. Medici, R. Kalluri (2012)Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype.
Seminars in cancer biology, 22 5-6
Pimprapa Vejpongsa, E. Yeh (2014)Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
Journal of the American College of Cardiology, 64 9
L. Eisenberg, R. Markwald (1995)Molecular regulation of atrioventricular valvuloseptal morphogenesis.
Circulation research, 77 1
G. Armstrong, V. Joshi, K. Ness, T. Marwick, N. Zhang, D. Srivastava, B. Griffin, R. Grimm, James Thomas, D. Phelan, P. Collier, K. Krull, D. Mulrooney, D. Green, M. Hudson, L. Robison, J. Plana (2015)Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.
Journal of the American College of Cardiology, 65 23
Benoît Ranchoux, F. Antigny, C. Rucker-Martin, A. Hautefort, C. Péchoux, H. Bogaard, P. Dorfmüller, S. Remy, F. Lecerf, Sylvie Planté, S. Chat, E. Fadel, Amal Houssaini, I. Anegon, S. Adnot, G. Simonneau, M. Humbert, S. Cohen-Kaminsky, F. Perros (2015)Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
Y. Ichikawa, Mohsen Ghanefar, Marina Bayeva, Rongxue Wu, Arineh Khechaduri, S. Prasad, R. Mutharasan, T. Naik, H. Ardehali (2014)Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.
The Journal of clinical investigation, 124 2
L. Tombor, S. Dimmeler (2022)Why is endothelial resilience key to maintain cardiac health?
Basic Research in Cardiology, 117
Kazuya Hori, Anindya Sen, S. Artavanis-Tsakonas (2013)Notch signaling at a glance
Journal of Cell Science, 126
J. Varga, S. Jimenez (1986)Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta.
Biochemical and biophysical research communications, 138 2
Licia Shamoon, J. Espitia-Corredor, P. Dongil, M. Menéndez-Ribes, A. Romero, Inés Valencia, G. Díaz-Araya, C. Sánchez-Ferrer, C. Peiró (2022)RESOLVIN E1 ATTENUATES DOXORUBICIN-INDUCED ENDOTHELIAL SENESCENCE BY MODULATING NLRP3 INFLAMMASOME ACTIVATION.
Huan He, Liang Wang, Y. Qiao, Bin Yang, D. Yin, M. He (2021)Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKα2 and activating adaptive autophagy
Redox Biology, 48
Weisen Wang, Zhi Wang, Dingyuan Tian, Xi Zeng, Yangdong Liu, Qining Fu, A. Liang, Yi Zhang, Q. Gao, Jizhong Cheng, Yun Wang (2018)Integrin β3 Mediates the Endothelial-to-Mesenchymal Transition via the Notch Pathway
Cellular Physiology and Biochemistry, 49
A. Penton, Laura Leonard, N. Spinner (2012)Notch signaling in human development and disease.
Seminars in cell & developmental biology, 23 4
S. Swain, F. Whaley, M. Ewer (2003)Congestive heart failure in patients treated with doxorubicin
Mingchuan Li, V. Sala, M. Santis, J. Cimino, P. Cappello, N. Pianca, A. Bona, J. Margaria, M. Martini, E. Lazzarini, F. Pirozzi, L. Rossi, I. Franco, Julia Bornbaum, J. Heger, S. Rohrbach, A. Perino, C. Tocchetti, B. Lima, M. Teixeira, P. Porporato, R. Schulz, A. Angelini, M. Sandri, P. Ameri, S. Sciarretta, R. Lima-Júnior, M. Mongillo, T. Zaglia, F. Morello, F. Novelli, E. Hirsch, A. Ghigo (2018)Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth
V. Todorova, Jeanne Wei, I. Makhoul (2021)Subclinical doxorubicin-induced cardiotoxicity update: role of neutrophils and endothelium.
American journal of cancer research, 11 9
Emma Wilkinson, J. Sidaway, M. Cross (2016)Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability
Biology Open, 5
John McGowan, R. Chung, A. Maulik, I. Piotrowska, J Walker, D. Yellon (2017)Anthracycline Chemotherapy and Cardiotoxicity
Cardiovascular Drugs and Therapy, 31
D. Gvaramia, M. Blaauboer, R. Hanemaaijer, V. Everts (2013)Role of caveolin-1 in fibrotic diseases.
Matrix biology : journal of the International Society for Matrix Biology, 32 6
X. Bosch, M. Rovira, M. Sitges, A. Doménech, J. Ortiz-Perez, T. Caralt, M. Morales-Ruiz, R. Perea, M. Monzó, J. Esteve (2013)Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of
Journal of the American College of Cardiology, 61 23
W. Deng, Xuebing Feng, Xia Li, Dandan Wang, Lingyun Sun (2016)Hypoxia-inducible factor 1 in autoimmune diseases.
Cellular immunology, 303
Jacqueline Chevalier, Hao Yin, J. Arpino, C. O’Neil, Z. Nong, Kevin Gilmore, Jason Lee, E. Prescott, Matthew Hewak, C. Rice, L. Dubois, A. Power, D. Hamilton, J. Pickering (2020)Obstruction of Small Arterioles in Patients with Critical Limb Ischemia due to Partial Endothelial-to-Mesenchymal Transition
J. Kovacic, N. Mercader, M. Torres, M. Boehm, V. Fuster (2012)Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition: From Cardiovascular Development to Disease
Kurt Stenmark, M. Frid, Frédéric Perros (2016)Endothelial-to-Mesenchymal Transition: An Evolving Paradigm and a Promising Therapeutic Target in PAH.
Circulation, 133 18
H. Xue, Wenhua Ren, M. Denkinger, E. Schlotzer, P. Wischmeyer (2016)Nutrition Modulation of Cardiotoxicity and Anticancer Efficacy Related to Doxorubicin Chemotherapy by Glutamine and ω-3 Polyunsaturated Fatty Acids.
JPEN. Journal of parenteral and enteral nutrition, 40 1
P. Mukhopadhyay, M. Rajesh, S. Batkai, Y. Kashiwaya, G. Haskó, L. Liaudet, C. Szabó, P. Pacher (2009)Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
American journal of physiology. Heart and circulatory physiology, 296 5
Xuetao Sun, Blessing Nkennor, Olya Mastikhina, Kayla Soon, Sara Nunes (2019)Endothelium-mediated contributions to fibrosis.
Seminars in cell & developmental biology
Marian Wesseling, T. Sakkers, S. Jager, Gerard Pasterkamp, M. Goumans (2018)The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis.
Vascular pharmacology, 106
BNM Zordoky, IM Robertson, JRB Dyck (2015)Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Biochem Biophys Acta, 1852
W. Qin, Longyin Zhang, Zhange Li, D. Xiao, Yue Zhang, Haiying Zhang, Justine Mokembo, Seth Monayo, Nabanit Jha, P. Kopylov, D. Shchekochikhin, Yong Zhang (2020)Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis
Ni Zhu, Guan-xin Zhang, B. Yi, Zhi-fu Guo, Soohwa Jang, Yong-qiang Yin, Fan Yang, R. Summer, Jianxin Sun (2019)Nur77 limits endothelial barrier disruption to LPS in the mouse lung.
American journal of physiology. Lung cellular and molecular physiology
Ju Liu, Fengyun Dong, James Jeong, Takahiro Masuda, C. Lobe (2014)Constitutively active Notch1 signaling promotes endothelial-mesenchymal transition in a conditional transgenic mouse model
International Journal of Molecular Medicine, 34
M. Frid, Vishakha Kale, K. Stenmark (2002)Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation: In Vitro Analysis
Circulation Research: Journal of the American Heart Association, 90
Lingzhi Li, Lijia Chen, J. Zang, Xi Tang, Yan Liu, Jie Zhang, Lin Bai, Q. Yin, Yanrong Lu, Jingqiu Cheng, P. Fu, Fang Liu (2015)C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Metabolism: clinical and experimental, 64 5
S. Swain, F. Whaley, Miriam Gerber, M. Ewer, J. Bianchine, R. Gams (1997)Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 4
J. Appel, D. Nielsen, B. Zerahn, B. Jensen, K. Skagen (2007)Anthracycline-induced chronic cardiotoxicity and heart failure
Acta Oncologica, 46
L. Meeteren, P. Dijke (2011)Regulation of endothelial cell plasticity by TGF-β
Cell and Tissue Research, 347
L. Polgár, E. Lajkó, P. Soós, O. Láng, M. Manea, B. Merkely, G. Mező, L. Kőhidai (2018)Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells
Beilstein Journal of Organic Chemistry, 14
J. Kwok, D. Richardson (2000)The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity
Redox Report, 5
V. Todorova, Y. Kaufmann, L. Hennings, V. Klimberg (2010)Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats.
The Journal of nutrition, 140 1
Markus Räsänen, Joni Degerman, T. Nissinen, I. Miinalainen, Risto Kerkelä, Antti Siltanen, J. Backman, E. Mervaala, J. Hulmi, R. Kivelä, K. Alitalo (2016)VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
Proceedings of the National Academy of Sciences, 113
Hai-ru Li, Chao Wang, Ping Sun, Dan Liu, G. Du, J. Tian (2020)Melatonin attenuates doxorubicin‐induced cardiotoxicity through preservation of YAP expression
Journal of Cellular and Molecular Medicine, 24
H. Sung, J. Ferlay, R. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray (2021)Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
CA: A Cancer Journal for Clinicians, 71
G. Takemura, H. Fujiwara (2007)Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Progress in cardiovascular diseases, 49 5
Barbara Carlson, M. Craft, John Carlson, W. Razaq, K. Deardeuff, D. Benbrook (2018)Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors
G. Sánchez-Duffhues, V. Orlova, P. Dijke (2016)In Brief: Endothelial‐to‐mesenchymal transition
The Journal of Pathology, 238
C. Heldin, A. Moustakas (2011)Role of Smads in TGFβ signaling
Cell and Tissue Research, 347
XY Chen, RJ Lv, W Zhang (2016)Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition
T. Tadokoro, Masataka Ikeda, T. Ide, Hiroko Deguchi, S. Ikeda, Kosuke Okabe, Akihito Ishikita, Shouji Matsushima, T. Koumura, Ken‐ichi Yamada, H. Imai, H. Tsutsui (2020)Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
JCI insight, 5 9
S. Evrard, L. Lecce, K. Michelis, A. Nomura-Kitabayashi, Gaurav Pandey, K. Purushothaman, Valentina d’Escamard, Jennifer Li, Lahouaria Hadri, K. Fujitani, P. Moreno, L. Bénard, P. Rimmelé, A. Cohain, B. Mecham, G. Randolph, E. Nabel, R. Hajjar, V. Fuster, M. Boehm, J. Kovacic (2016)Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability
Nature Communications, 7
P. Spallarossa, S. Garibaldi, P. Altieri, P. Fabbi, V. Manca, S. Nasti, P. Rossettin, G. Ghigliotti, A. Ballestrero, F. Patrone, A. Barsotti, C. Brunelli (2004)Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
Journal of molecular and cellular cardiology, 37 4
P. Gasperini, G. Espigol-Frigolé, P. McCormick, O. Salvucci, D. Maric, T. Uldrick, M. Polizzotto, R. Yarchoan, G. Tosato (2012)Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.
Cancer research, 72 5
L. Kobashigawa, Yanchun Xu, J. Padbury, Y. Tseng, N. Yano (2014)Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study
PLoS ONE, 9
Yucheng Yao, M. Jumabay, Albert Ly, M. Radparvar, Mark Cubberly, K. Boström (2013)A Role for the Endothelium in Vascular Calcification
Circulation Research, 113
Seo-Hyun Choi, Z. Hong, J. Nam, Hae-June Lee, Junho Jang, R. Yoo, Yong-Jin Lee, Chang Lee, Kyung Kim, Seungwoo Park, Young-Hoon Ji, Yun‐Sil Lee, Jaeho Cho, Yoon-Jin Lee (2015)A Hypoxia-Induced Vascular Endothelial-to-Mesenchymal Transition in Development of Radiation-Induced Pulmonary Fibrosis
Clinical Cancer Research, 21
Wen‐Pin Huang, W. Yin, Jia-Shiong Chen, Po‐Hsun Huang, Jaw-wen Chen, Shing-Jong Lin (2021)Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
Scientific Reports, 11
M. Avila, S. Ayub-Ferreira, Mauro Wanderley, Fatima Cruz, Sara Brandão, V. Rigaud, M. Higuchi-Dos-Santos, L. Hajjar, R. Filho, P. Hoff, Marina Sahade, M. Ferrari, Romulo Costa, M. Mano, Cecilia Cruz, M. Abduch, Marco Alves, G. Guimãraes, V. Issa, M. Bittencourt, E. Bocchi (2018)Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial.
Journal of the American College of Cardiology, 71 20
D. Hanahan, R. Weinberg (2011)Hallmarks of Cancer: The Next Generation
K. Chatterjee, Jianqing Zhang, N. Honbo, J. Karliner (2009)Doxorubicin Cardiomyopathy
R. Young, R. Ozols, C. Myers (1981)The anthracycline antineoplastic drugs.
The New England journal of medicine, 305 3
Zhiyang Li, Xuelian Li, Yeqian Zhu, Qiushi Chen, Bingong Li, Fengxiang Zhang (2020)Protective effects of acetylcholine on hypoxia-induced endothelial-to-mesenchymal transition in human cardiac microvascular endothelial cells
Molecular and Cellular Biochemistry, 473
Seo-Hyun Choi, Alissa Kim, J. Nam, Jin-Mo Kim, Jee-Youn Kim, H. Seo, Hae-June Lee, Jaeho Cho, Yoon-Jin Lee (2018)Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization
Nature Communications, 9
B. Kalyanaraman (2019)Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
Redox Biology, 29
Seonghwan Hwang, K. Chung (2021)Targeting fatty acid metabolism for fibrotic disorders
Archives of Pharmacal Research, 44
G. Gulati, S. Heck, H. Røsjø, A. Ree, P. Hoffmann, T. Hagve, J. Norseth, B. Gravdehaug, K. Steine, J. Geisler, T. Omland (2017)Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6
R. Cabral, T. Mendes, V. Vendramini, S. Miraglia (2018)Carnitine partially improves oxidative stress, acrosome integrity, and reproductive competence in doxorubicin‐treated rats
Nadine Wenningmann, Merle Knapp, Anusha Ande, Tanaya Vaidya, S. Ait-Oudhia (2019)Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Molecular Pharmacology, 96
Wanjun Ma, Shan-shan Wei, Bi-kui Zhang, Wenqun Li (2020)Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity
Frontiers in Cell and Developmental Biology, 8
Alex Chang, YangXin Fu, Victoria Garside, Kyle Niessen, L. Chang, Megan Fuller, A. Setiadi, Justin Smrz, A. Kyle, A. Minchinton, M. Marra, P. Hoodless, A. Karsan (2011)Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase.
Developmental cell, 21 2
Zhaodong Li, P. Wermuth, B. Benn, M. Lisanti, S. Jimenez (2013)Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro.
The American journal of pathology, 182 2
E. Pardali, G. Sánchez-Duffhues, M. Gomez-Puerto, P. Dijke (2017)TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
International Journal of Molecular Sciences, 18
A. Leask (2015)Getting to the heart of the matter: new insights into cardiac fibrosis.
Circulation research, 116 7
Emma Lefrançais, Guadalupe Ortiz-Muñoz, A. Caudrillier, B. Mallavia, Fengchun Liu, D. Sayah, E. Thornton, M. Headley, T. David, S. Coughlin, M. Krummel, A. Leavitt, E. Passegué, M. Looney (2017)The lung is a site of platelet biogenesis and a reservoir for hematopoietic progenitors
Mary Choi, David Price, S. Ryter, A. Choi (2019)Necroptosis: a crucial pathogenic mediator of human disease.
JCI insight, 4 15
J. Kovacic, S. Dimmeler, R. Harvey, T. Finkel, E. Aikawa, G. Krenning, A. BakerEndothelial to Mesenchymal Transition
Xiaofeng Cui, Yao Lu, V. Lee, Diana Kim, T. Dorsey, Qing-jie Wang, Young Lee, P. Vincent, J. Schwarz, G. Dai (2015)Venous Endothelial Marker COUP-TFII Regulates the Distinct Pathologic Potentials of Adult Arteries and Veins
Scientific Reports, 5
V. Rocha, L. França, C. Araújo, Ayling Ng, Candace Andrade, A. Andrade, Emanuelle Santos, Mariana Borges-Silva, S. Macambira, A. Noronha-Dutra, L. Pontes-de-carvalho (2016)Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice
Cancer Chemotherapy and Pharmacology, 77
Kai Zhu, Q. Pan, Luo-qi Jia, Z. Dai, A. Ke, H. Zeng, Zhao-You Tang, Jia Fan, Jian Zhou (2014)MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells
Scientific Reports, 4
E. Arciniegas, Carmen Neves, L. Carrillo, E. Zambrano, Richard Ramírez (2005)Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development.
Endothelium : journal of endothelial cell research, 12 4
D. Medici, S. Potenta, R. Kalluri (2011)Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling.
The Biochemical journal, 437 3
Zhen Yang, Li-jie He, Shiren Sun (2019)Role of Endothelial Cells in Renal Fibrosis.
Advances in experimental medicine and biology, 1165
E. Glover, Nina Jordan, N. Sheerin, Simi Ali (2019)Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction.
Tzu-hsien Tsai, Cheng-Jei Lin, C. Hang, Wei‐Yu Chen (2019)Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice
S. Soldano, S. Paolino, C. Pizzorni, A. Trombetta, P. Montagna, R. Brizzolara, C. Corallo, N. Giordano, A. Sulli, M. Cutolo (2017)Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.
Clinical and experimental rheumatology, 35 3
Z. Clayton, David Hutton, S. Mahoney, D. Seals (2021)Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging
Aging and Cancer, 2
Hsuan‐Fu Kuo, I-Fan Liu, Chia-Yang Li, Chien-Sung Tsai, Yung-Hsiang Chen, W. Lian, Tzu-Chieh Lin, Yu-Ru Liu, Tsung-Ying Lee, Chi-Yuan Huang, C. Hsieh, Chih-Hsin Hsu, F. Lin, Po-Len Liu (2021)Endocardial Endothelial Dysfunction and Unknown Polymorphic Composite Accumulation in Heart Failure
F. Galdo, M. Lisanti, S. Jimenez (2008)Caveolin-1, transforming growth factor-β receptor internalization, and the pathogenesis of systemic sclerosis
Current Opinion in Rheumatology, 20
D. Cardinale, A. Colombo, G. Bacchiani, I. Tedeschi, C. Meroni, F. Veglia, M. Civelli, Giuseppina Lamantia, N. Colombo, G. Curigliano, C. Fiorentini, C. Cipolla (2015)Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
P. Oliveira, J. Bjork, Maria Santos, R. Leino, M. Froberg, A. Moreno, K. Wallace (2004)Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Toxicology and applied pharmacology, 200 2
M. Bansal (2013)Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of
Indian heart journal, 65
A. Lagendijk, A. Szabó, Roeland Merks, J. Bakkers (2013)Hyaluronan: a critical regulator of endothelial-to-mesenchymal transition during cardiac valve formation.
Trends in cardiovascular medicine, 23 5
L. Pérez, N. Muñoz-Durango, C. Riedel, C. Echeverria, A. Kalergis, C. Cabello-Verrugio, F. Simon (2017)Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions.
Cytokine & growth factor reviews, 33
Guizhen Zhao, Haocheng Lu, Yuhao Liu, Yang Zhao, Tianqing Zhu, M. Garcia-Barrio, Y. Chen, Jifeng Zhang (2021)Single-Cell Transcriptomics Reveals Endothelial Plasticity During Diabetic Atherogenesis
Frontiers in Cell and Developmental Biology, 9
Jieli Li, Hui-Ming Chang, J. Banchs, D. Araujo, Saamir Hassan, E. Wagar, E. Yeh, Q. Meng (2020)Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Q. Lin, J. Zhao, Chongzhou Zheng, J. Chun (2018)Roles of notch signaling pathway and endothelial-mesenchymal transition in vascular endothelial dysfunction and atherosclerosis.
European review for medical and pharmacological sciences, 22 19
Anji Xu, Feiyan Deng, Yongyi Chen, Yu Kong, Lijun Pan, Q. Liao, Z. Rao, Luyuan Xie, C. Yao, Sha Li, Xiaoling Zeng, Xiaomei Zhu, Huayun Liu, Nina Gao, Lei Xue, Fen Chen, Guoxing Xu, D. Wei, Xiao Zhou, Zan Li, Xiaowu Sheng (2020)NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 130
Zuyue Sun, Jill Schriewer, Mingxin Tang, Jerry Marlin, F. Taylor, R. Shohet, E. Konorev (2016)The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.
Journal of molecular and cellular cardiology, 90
H Sung (2021)209
CA Cancer J Clin, 71
F. Akdemir, S. Yıldırım, F. Kandemir, A. Tanyeli̇, S. Küçükler, Muhammed Dortbudak (2019)Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study
Archives of Physiology and Biochemistry, 127
B. Asselin, M. Devidas, Lu Chen, V. Franco, J. Pullen, M. Borowitz, R. Hutchison, Y. Ravindranath, S. Armenian, B. Camitta, S. Lipshultz (2016)Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 8
M. Rudd, M. Johnstone, L. Rabbani, D. George, J. Ware, J. Loscalzo (1991)Thrombolytic Therapy Causes an Increase in Vascular Permeability That Is Reversed by 1‐Deamino‐8‐D‐Vasopressin
P. Wermuth, Zhaodong Li, F. Mendoza, S. Jimenez (2016)Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1
PLoS ONE, 11
E. Cortes, Dariusz Lachowski, Benjamin Robinson, Muge Sarper, Jaakko Teppo, S. Thorpe, Tyler Lieberthal, K. Iwamoto, D. Lee, M. Okada‐Hatakeyama, M. Varjosalo, Armando Hernández (2018)Tamoxifen mechanically reprograms the tumor microenvironment via HIF‐1A and reduces cancer cell survival
EMBO Reports, 20
David Gonzalez, D. Medici (2014)Signaling mechanisms of the epithelial-mesenchymal transition
Science Signaling, 7
L. Meng, Hui-Kuan Lin, Jie Zhang, N. Lin, Zhenzhu Sun, F. Gao, Hangqi Luo, T. Ni, Wenqiang Luo, J. Chi, Hangyuan Guo (2019)Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.
Journal of molecular and cellular cardiology
M. Goumans, A. Zonneveld, P. Dijke (2008)Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?
Trends in cardiovascular medicine, 18 8
M. Noseda, Graeme McLean, Kyle Niessen, L. Chang, I. Pollet, Rachel Montpetit, R. Shahidi, K. Dorovini‐Zis, Linheng Li, B. Beckstead, R. Durand, P. Hoodless, A. Karsan (2004)Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation
Circulation Research: Journal of the American Heart Association, 94
J. Patel, Betoul Baz, H. Wong, James Lee, K. Khosrotehrani (2017)Accelerated Endothelial to Mesenchymal Transition Increased Fibrosis via Deleting Notch Signaling in Wound Vasculature.
The Journal of investigative dermatology, 138 5
Jennifer Richards, I. El-Hamamsy, Si Chen, Zubair Sarang, P. Sarathchandra, M. Yacoub, A. Chester, J. Butcher (2013)Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling.
The American journal of pathology, 182 5
Yonghe Ding, Xiaojing Sun, Wei Huang, Tiffany Hoage, M. Redfield, S. Kushwaha, S. Sivasubbu, Xueying Lin, S. Ekker, Xiaolei Xu (2011)Haploinsufficiency of Target of Rapamycin Attenuates Cardiomyopathies in Adult Zebrafish
Circulation Research, 109
S. Piera-velázquez, Zhaodong Li, S. Jimenez (2011)Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.
The American journal of pathology, 179 3
Lisa Kopp, R. Womer, C. Schwartz, D. Ebb, V. Franco, David Hall, D. Barkauskas, M. Krailo, H. Grier, P. Meyers, L. Wexler, N. Marina, K. Janeway, R. Gorlick, M. Bernstein, S. Lipshultz (2019)Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
Se-Hyuk Kim, Yeonhwa Song, H. Seo (2019)GSK-3β regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models
Journal of Experimental & Clinical Cancer Research : CR, 38
Cai-Yu Zeng, Jia Xu, Xin Liu, Yuan-qiang Lu (2021)Cardioprotective Roles of Endothelial Progenitor Cell-Derived Exosomes
Frontiers in Cardiovascular Medicine, 8
Ye-qing Xie, Jianquan Liao, Yong Yu, Q. Guo, Ying-zhen Yang, J. Ge, Hao-zhu Chen, Ruizhen Chen (2017)Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
Molecular Medicine Reports, 17
S. Lipshultz, V. Franco, S. Sallan, P. Adamson, R. Steiner, S. Swain, J. Gligorov, G. Minotti (2014)Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: An update of the evidence
Progress in Pediatric Cardiology, 36
Xiaohang Qiao, Sabina Zanden, Dennis Wander, D. Borràs, Ji-Ying Song, Xiaoyang Li, Suzanne Duikeren, N. Gils, A. Rutten, Tessa Herwaarden, O. Tellingen, Elisa Giacomelli, M. Bellin, V. Orlova, L. Tertoolen, Sophie Gerhardt, Jimmy Akkermans, J. Bakker, C. Zuur, Baoxu Pang, A. Smits, C. Mummery, L. Smit, R. Arens, Junmin Li, H. Overkleeft, J. Neefjes (2020)Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Proceedings of the National Academy of Sciences of the United States of America, 117
X Fang, H Wang, D Han (2019)Ferroptosis as a target for protection against cardiomyopathy
Proc Natl Acad Sci USA, 116
A. Arinno, C. Maneechote, T. Khuanjing, B. Ongnok, N. Prathumsap, T. Chunchai, B. Arunsak, Sasiwan Kerdphoo, K. Shinlapawittayatorn, S. Chattipakorn, N. Chattipakorn (2021)Cardioprotective Effects of Melatonin and Metformin Against Doxorubicin-induced Cardiotoxicity in Rats are Through Preserving Mitochondrial Function and Dynamics.
X. Fang, Hao Wang, Dan Han, Enjun Xie, Xiang Yang, Jiayu Wei, Shanshan Gu, F. Gao, N. Zhu, Xiangju Yin, Qi Cheng, Pan Zhang, Wei Dai, Jinghai Chen, Fuquan Yang, Huang-Tian Yang, A. Linkermann, W. Gu, J. Min, Fudi Wang (2019)Ferroptosis as a target for protection against cardiomyopathy
Proceedings of the National Academy of Sciences of the United States of America, 116
H. Sonowal, P. Pal, K. Shukla, A. Saxena, S. Srivastava, K. Ramana (2018)Aldose reductase inhibitor, fidarestat prevents doxorubicin‐induced endothelial cell death and dysfunction
Biochemical Pharmacology, 150
Jinyu Zhang, Samuel Rojas, Sanjay Singh, P. Musich, M. Gutiérrez, Z. Yao, D. Thewke, Yong-chao Jiang (2021)Wnt2 Contributes to the Development of Atherosclerosis
Frontiers in Cardiovascular Medicine, 8
H. Shoukry, H. Ammar, L. Rashed, M. Zikri, A. Shamaa, Sahar Elfadl, E. Rub, S. Saravanan, S. Dhingra (2017)Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
PLoS ONE, 12
Harika Sabbineni, A. Verma, P. Somanath (2018)Isoform‐specific effects of transforming growth factor β on endothelial‐to‐mesenchymal transition
Journal of Cellular Physiology, 233
Bo Zhang, W. Niu, Hai-ying Dong, Manling Liu, Ying Luo, Zhi-chao Li (2018)Hypoxia induces endothelial-mesenchymal transition in pulmonary vascular remodeling
International Journal of Molecular Medicine, 42
Yong Zhang, Xian-xian Wu, Yang Li, Haiying Zhang, Zhange Li, Ying Zhang, Longyin Zhang, Jiaming Ju, Xin Liu, Xiaohui Chen, P. Glybochko, V. Nikolenko, P. Kopylov, Chaoqian Xu, Baofeng Yang (2016)Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis
Scientific Reports, 6
N. Kalay, Emrullah Başar, I. Ozdoğru, O. Er, Yakup Çetinkaya, A. Dogan, Tuğrul Inanç, A. Oguzhan, N. Eryol, R. Topsakal, A. Ergin (2006)Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
Journal of the American College of Cardiology, 48 11
B. Sishi, B. Loos, J. Rooyen, A. Engelbrecht (2013)Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Biochemical pharmacology, 85 1
Anthoula Arta, J. Larsen, A. Eriksen, P. Kempen, Michael Larsen, T. Andresen, A. Urquhart (2020)Cell targeting strategy affects the intracellular trafficking of liposomes altering loaded doxorubicin release kinetics and efficacy in endothelial cells.
International journal of pharmaceutics
C. Niehrs (2012)The complex world of WNT receptor signalling
Nature Reviews Molecular Cell Biology, 13
S. Dixon, K. Lemberg, M. Lamprecht, R. Skouta, E. Zaitsev, Caroline Gleason, Darpan Patel, Andras Bauer, Alexandra Cantley, W. Yang, B. Morrison, B. Stockwell (2012)Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
CH Heldin, A Moustakas (2012)Role of Smads in TGFbeta signaling
Cell Tissue Res, 347
W. Ciszewski, Marta Wawro, Izabela Sacewicz-Hofman, K. Sobierajska (2021)Cytoskeleton Reorganization in EndMT—The Role in Cancer and Fibrotic Diseases
International Journal of Molecular Sciences, 22
Hui Peng, Yuanqing Li, Cheng Wang, Jun Zhang, Yanru Chen, Wen-fang Chen, Jin Cao, Yanlin Wang, Zhaoyong Hu, T. Lou (2016)ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy
Scientific Reports, 6
A. Luu, B. Chowdhury, M. Al-Omran, H. Teoh, D. Hess, S. Verma (2018)Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
JACC: Basic to Translational Science, 3
J. Huelsenbeck, C. Henninger, A. Schad, K. Lackner, B. Kaina, G. Fritz (2011)Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
Cell Death & Disease, 2
Sae-Won Lee, Joo-Yun Won, W. Kim, Jae-Woong Lee, K. Kim, Seock-Won Youn, Ju-Young Kim, Eunjin Lee, Yong-Jin Kim, Kyu-Won Kim, Hyo-Soo Kim (2013)Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis.
Molecular therapy : the journal of the American Society of Gene Therapy, 21 9
Sui Zhang, Xiaobing Liu, Tasneem Bawa-Khalfe, Long‐Sheng Lu, Y. Lyu, Leroy Liu, E. Yeh (2012)Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Nature Medicine, 18
AB Roberts, MB Sporn, RK Assoian (1986)Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
Proc Natl Acad Sci USA, 83
D. Hoff, M. Layard, Peter Basa, H. Davis, Ann Hoff, M. Rozencweig, F. Muggia (1979)Risk factors for doxorubicin-induced congestive heart failure.
Annals of internal medicine, 91 5
Zheng Wang, Zhong-Min Wang, Lu Gao, Lili Xiao, R. Yao, Binbin Du, Yapeng Li, Leiming Wu, C. Liang, Zhen Huang, Pengcheng Li, Yanzhou Zhang (2020)miR‐222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β‐catenin‐mediated endothelium to mesenchymal transition
Journal of Cellular Physiology, 235
C. Bergmann, J. Distler (2016)Canonical Wnt signaling in systemic sclerosis
Laboratory Investigation, 96
Jingang Hou, Yeejin Yun, C. Cui, Sunchang Kim (2022)Ginsenoside Rh2 mitigates doxorubicin‐induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer‐bearing mice
Cell Proliferation, 55
M. Najafi, M. Shayesteh, K. Mortezaee, Bagher Farhood, Hamed Haghi-Aminjan (2019)The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review.
X Qiao, SY van der Zanden, DPA Wander (2020)Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Proc Natl Acad Sci USA, 117
R. Nusse, H. Clevers (2017)Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
S. Jahn, Tatiana Hennicke, M. Kassack, Leonie Drews, A. Reichert, G. Fritz (2020)Distinct influence of the anthracycline derivative doxorubicin on the differentiation efficacy of mESC-derived endothelial progenitor cells.
Biochimica et biophysica acta. Molecular cell research
Jie Wang(a), Jingjing Zhang, Mengjie Xiao, Shudong Wang, Jie Wang(b), Yuanfang Guo, Yufeng Tang, J. Gu (2021)Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways
Cellular and Molecular Life Sciences, 78
R. Damiani, D. Moura, C. Viau, R. Caceres, J. Henriques, J. Saffi (2016)Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Archives of Toxicology, 90
Minsik Park, Joohwan Kim, Taesam Kim, Suji Kim, Wonjin Park, Kwon-Soo Ha, S. Cho, M. Won, Jeong-Hyung Lee, Young-Guen Kwon, Young-Myeong Kim (2021)REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression
Experimental & Molecular Medicine, 53
M. Oliveira, M. Melo, J. Carvalho, Isabela Melo, Mario Lavor, D. Gomes, A. Goes, M. Melo (2013)Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.
Journal of cancer science & therapy, 5 2
K. Mccormack (2018)The cardioprotective effect of dexrazoxane (Cardioxane) is consistent with sequestration of poly(ADP-ribose) by self-assembly and not depletion of topoisomerase 2B
SM Swain, FS Whaley, MS Ewer (2003)Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials
Jian-an Pan, H. Zhang, Hao Lin, Lin Gao, Hui-li Zhang, Junfeng Zhang, Chang-qian Wang, Jun Gu (2021)Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
Redox Biology, 46
Xingbo Xu, Xiaoying Tan, B. Tampe, E. Sánchez, M. Zeisberg, E. Zeisberg (2015)Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells*
The Journal of Biological Chemistry, 290
M. Khouri, P. Douglas, J. Mackey, Miguel Martín, Jessica Scott, M. Scherrer-Crosbie, L. Jones (2012)Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer: Addressing the Unresolved Issues
Cynthia Chude, R. Amaravadi (2017)Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors
International Journal of Molecular Sciences, 18
Katherine Courchaine, S. Rugonyi (2019)Optical coherence tomography for in vivo imaging of endocardial to mesenchymal transition during avian heart development.
Biomedical optics express, 10 11
M Räsänen, J Degerman, TA Nissinen (2016)VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
Proc Natl Acad Sci USA, 113
S. Foulquier, E. Daskalopoulos, G. Lluri, Kevin Hermans, Arjun Deb, W. Blankesteijn (2018)WNT Signaling in Cardiac and Vascular Disease
Pharmacological Reviews, 70
Jingu Cho, Aram Lee, Woochul Chang, Myeong-Sok Lee, Jongmin Kim (2018)Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction
Frontiers in Immunology, 9
Valentin Platel, S. Faure, I. Corre, N. Clere (2019)Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance
Journal of Oncology, 2019
Shaohua Zhang, Yan Li, Xiuzhen Huang, Kuo Liu, Qing-Dong Wang, Alex Chen, K. Sun, K. Lui, Bin Zhou (2021)Seamless Genetic Recording of Transiently Activated Mesenchymal Gene Expression in Endothelial Cells During Cardiac Fibrosis
S. Piera-velázquez, S. Jimenez (2012)Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases
Fibrogenesis & Tissue Repair, 5
Jie Yu, Changxi Wang, Q. Kong, Xiaxia Wu, Jin-jian Lu, Xiuping Chen (2018)Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 40
E. Zeisberg, O. Tarnavski, M. Zeisberg, A. Dorfman, J. McMullen, E. Gustafsson, A. Chandraker, Xueli Yuan, W. Pu, A. Roberts, E. Neilson, M. Sayegh, S. Izumo, R. Kalluri (2007)Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Nature Medicine, 13
The use of chemotherapeutic agents is becoming more frequent as the proportion of new oncology patients increases worldwide, with prolonged survival after treatment. As one of the most popular chemotherapy drugs, doxorubicin plays a substantial role in the treatment of tumors. Unfortunately, the use of doxorubicin is associated with several adverse effects, particularly severe cardiotoxicity that can be life-threatening, which greatly limits its clinical use. For decades, scientists have tried to explore many cardioprotective agents and therapeutic approaches, but their efficacy remains controversial, and some drugs have even brought about significant adverse effects. The concrete molecular mechanism of doxorubicin-induced cardiotoxicity is still to be unraveled, yet endothelial damage is gradually being identified as an important mechanism triggering the development and progression of doxorubicin-induced cardiotoxicity. Endothelial-to-mesenchymal transition (EndMT), a fundamental process regulating morphogenesis in multicellular organisms, is recognized to be associated with endothelial damage repair and acts as an important factor in the progression of cardiovascular diseases, tumors, and rheumatic immune diseases. Mounting evidence suggests that endothelial–mesenchymal transition may play a non-negligible role in doxorubicin-induced cardiotoxicity. In this paper, we reviewed the molecular mechanisms and signaling pathways of EndMT and outlined the molecular mechanisms of doxorubicin-induced cardiotoxicity and the current therapeutic advances. Furthermore, we summarized the basic principles of doxorubicin-induced endothelial–mesenchymal transition that lead to endothelial dysfunction and cardiotoxicity, aiming to provide suggestions or new ideas for the prevention and treatment of doxorubicin-induced endothelial and cardiac injury.
American Journal of Cardiovascular Drugs – Springer Journals
Published: May 1, 2023
Access the full text.
Sign up today, get DeepDyve free for 14 days.